Hi again !!
I had previously responded for the query
Let me elaborate further ..
There are 3 things that require clarification in your case
1 what is the stage ?
2 If stage 2 then what is MSI status ?
3 whether high risk features present or absent ?
Patients with properly evaluated pathological STAGE II, without high-risk features and who have MSI-unstable (MSI-H)/dMMR tumors have a favorable prognosis and are not likely to derive "SIGNIFICANT" benefit from chemotherapy in adjuvant setting.
Paraffin embedded Tissue blocks are necessary for MSI testing ..
Hope I made things clear ..
All the best ..warm regards
Answered2017-08-25 18:00:01
0/1 people found this helpful